RESUMO
Introduction: Vascular ulcers constitute a serious global public health problem, responsible for causing a significant social and economic impact due to their recurrent, disabling nature and the need for prolonged therapies to cure them. Objective: To evaluate the use and efficacy of the rhEGF in the epithelialization of patients with a diagnosis of CEAP stage 6 venous insufficiency, in the two regimes of the health system in Colombia, the contributive (equivalent to a health system where citizens with payment capacity contribute a percentage of their salary) and the subsidized (equivalent to a health system where the state covers the vulnerable population and low socioeconomic level) versus the other treatments used. Methodology: Observational, descriptive, retrospective, multicenter study, in which 105 medical records with 139 ulcers were reviewed, in 2 centers, one belonging to the subsidized system and the other to the contributive system in Colombia. Results: The association with the epithelialization variable of the different treatment groups for ulcers according to the application of the mixed effect model test, for both regimes was for the Biologicals (EC 34.401/p = 0.000), Bioactive Agents (Hydrogels) (EC 24.735/p = 0.005) groups; for the rest of the treatment groups, the results were neither associated nor statistically significant. Conclusion: Intra- and perilesional therapy with rhEGF expands the therapeutic spectrum in patients with venous ulcers, regardless of the type of health system in which it will be applied, shortening the healing time and reaching a possible therapeutic goal, which according to this study there is an association with epithelialization regardless of the regime applied.
Assuntos
Úlcera Varicosa , Humanos , Colômbia , Úlcera Varicosa/tratamento farmacológico , Úlcera Varicosa/economia , Estudos Retrospectivos , Masculino , Feminino , Pessoa de Meia-Idade , Fator de Crescimento Epidérmico , Proteínas Recombinantes/economia , Proteínas Recombinantes/uso terapêutico , Proteínas Recombinantes/administração & dosagem , IdosoRESUMO
Chronic wounds are characterized by prolonged non-healing, significantly affecting patients' quality of life. Oral formulas may enhance the wound healing process and contribute to cost reduction in care. This review aimed to evaluate the effects of oral nutritional supplementation on chronic wound healing and provide insights into formula characteristics. A comprehensive search across Cinahl, Embase, PubMed, and Web of Science databases yielded nine studies from the past decade involving 741 patients ages 52 to 81.7 across various care settings: hospitals, long-term care facilities, and home care. Primary wound types included pressure injuries (58%), diabetic foot ulcers (40%), and venous ulcers (2%). The intervention duration ranged from 2 to 16 wk, with sample sizes varying from 24 to 270 patients. Notably, four studies reported a reduction in wound area and an increased healing rate with a hypercaloric, hyperproteic formula enriched with zinc and vitamins A, C, and E. However, two studies found no significant differences compared with control groups. Two other studies investigated a combination of arginine, glutamine, and ß-hydroxy-ß-methylbutyrate; however, they did not yield significant results, and one study favored a hyperproteic formula instead of a hyperproteic formula with arginine. This review provides evidence supporting the potential of oral nutritional supplementation to enhance the healing process of chronic wounds. Based on our findings, a desirable formula should be characterized by a high calorie and protein content and the inclusion of antioxidant micronutrients, including, but not limited to, vitamins A, E, C, and zinc.
Assuntos
Suplementos Nutricionais , Úlcera por Pressão , Cicatrização , Humanos , Cicatrização/efeitos dos fármacos , Doença Crônica , Pé Diabético/terapia , Zinco/administração & dosagem , Úlcera Varicosa/dietoterapia , Úlcera Varicosa/terapia , Idoso , Arginina/administração & dosagem , Arginina/farmacologia , Pessoa de Meia-Idade , Idoso de 80 Anos ou mais , Valeratos/administração & dosagem , Valeratos/farmacologia , Vitamina A/administração & dosagem , Glutamina/administração & dosagem , Vitamina E/administração & dosagem , Vitamina E/farmacologia , Ácido Ascórbico/administração & dosagem , Ácido Ascórbico/farmacologia , Feminino , Vitaminas/administração & dosagem , Masculino , Administração OralRESUMO
Introducción: El cuidado de las úlceras vasculares venosas se ha considerado un problema de salud pública por su alta incidencia e impacto social y económico que genera. Objetivo: Determinar los costos directos del cuidado de enfermería en personas con úlcera vascular venosa atendidas por un prestador de servicios de salud en la ciudad de Bogotá. Materiales y métodos: Estudio observacional, descriptivo, retrospectivo, realizado entre el 1 enero de 2019 y el 31 de enero de 2020; el cual se basó, en la revisión de historias clínicas de personas con úlcera vascular venosa. La muestra estuvo conformada por 52 historias clínicas, seleccionadas mediante un instrumento de valoración de enfermería. Las variables que se analizaron fueron la edad y el sexo, utilizando estadística descriptiva y el análisis del costo. Resultados: El sexo predominante fue el femenino (69,24%) y la edad promedio de 64 años. El costo directo fue de 70.109.504.76 COP y la estimación promedio 1.348.259 COP, valor que incluyó el costo de apósitos, elastocompresión, limpieza y consulta. Conclusión: Los costos en el cuidado de las úlceras vasculares venosas están inmersos en los paquetes de atención, que incluyen los costos de curación y consulta; sin embargo, no son explícitos para enfermería.
Introduction: The venous vascular ulcers care has become a public health problem due to its high incidence and the social and economic impact it causes. Objective: To determine the direct costs of nursing care of people with venous vascular ulcers treated at a health service provider facility in Bogota, Colombia. Materials and methods: Observational, descriptive, retrospective study carried out between January 1, 2019 and January 31, 2020, which focused on the review of medical records of patients with venous vascular ulcer. The sample included 52 medical records that were selected through a nursing assessment instrument. The variables of age and gender were analyzed through descriptive statistics and cost analysis. Results: Female was the predominant gender (69.24%) and the average age was 64 years. The direct cost was $70.109.504.76 COP, whereas the average estimate was $1.348.259 COP, which included the cost of dressings, elastocompression, cleaning, and consultation. Conclusion: The costs of venous vascular ulcers care are included in the care packages, which include costs of healing and consultation. Nevertheless, they are not explicit for nursing.
Introdução: O atendimento às úlceras vasculares venosas tem sido considerado um problema de saúde pública devido à alta incidência e ao impacto social e econômico que gera. Objetivo: Determinar os custos diretos da assistência de enfermagem a pessoas com úlceras vasculares venosas atendidas por um serviço de saúde na cidade de Bogotá. Materiais e métodos: Estudo observacional, descritivo, retrospectivo, realizado entre 1º de janeiro de 2019 e 31 de janeiro de 2020; que se baseou na revisão de prontuários de pessoas com úlcera vascular venosa. A amostra foi composta por 52 prontuários, selecionados por meio de instrumento de avaliação de enfermagem. As variáveis analisadas foram idade e sexo, por meio de estatística descritiva e análise de custos. Resultados: O sexo predominante foi o feminino (69,24%) e a média de idade foi de 64 anos. O custo direto foi de 70.109.504,76 COP e a estimativa média foi de 1.348.259 COP, valor que incluiu o custo de curativos, elastocompressão, limpeza e consulta. Conclusão: Os custos no cuidado das úlceras vasculares venosas estão embutidos nos pacotes de cuidados, que incluem os custos de cura e consulta; entretanto, não são explícitos para a enfermagem.
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Custos de Cuidados de Saúde , Úlcera da Perna , Úlcera Varicosa , Custos Diretos de Serviços , Comorbidade , Custos de Medicamentos , Custos HospitalaresRESUMO
BACKGROUND: Up to 1% of adults will have a leg ulcer at some time. Most leg ulcers are venous in origin and are caused by high pressure in the veins due to blockage or damaged valves. Venous ulcer prevention and treatment typically involves the application of compression bandages/stockings to improve venous return and thus reduce pressure in the legs. Other treatment options involve removing or repairing veins. Most venous ulcers heal with compression therapy, but ulcer recurrence is common. For this reason, clinical guidelines recommend that people continue with compression treatment after their ulcer has healed. This is an update of a Cochrane review first published in 2000 and last updated in 2014. OBJECTIVES: To assess the effects of compression (socks, stockings, tights, bandages) for preventing recurrence of venous leg ulcers. SEARCH METHODS: In August 2023, we searched the Cochrane Wounds Specialised Register, CENTRAL, MEDLINE, Embase, three other databases, and two ongoing trials registries. We also scanned the reference lists of included studies and relevant reviews and health technology reports. There were no restrictions on language, date of publication, or study setting. SELECTION CRITERIA: We included randomised controlled trials (RCTs) that evaluated compression bandages or hosiery for preventing the recurrence of venous ulcers. DATA COLLECTION AND ANALYSIS: At least two review authors independently selected studies, assessed risk of bias, and extracted data. Our primary outcome was reulceration (ulcer recurrence anywhere on the treated leg). Our secondary outcomes included duration of reulceration episodes, proportion of follow-up without ulcers, ulceration on the contralateral leg, noncompliance with compression therapy, comfort, and adverse effects. We assessed the certainty of evidence using GRADE methodology. MAIN RESULTS: We included eight studies (1995 participants), which were published between 1995 and 2019. The median study sample size was 249 participants. The studies evaluated different classes of compression (UK class 2 or 3 and European (EU) class 1, 2, or 3). Duration of follow-up ranged from six months to 10 years. We downgraded the certainty of the evidence for risk of bias (lack of blinding), imprecision, and indirectness. EU class 3 compression stockings may reduce reulceration compared with no compression over six months (risk ratio (RR) 0.46, 95% confidence interval (CI) 0.27 to 0.76; 1 study, 153 participants; low-certainty evidence). EU class 1 compression stockings compared with EU class 2 compression stockings may have little or no effect on reulceration over 12 months (RR 1.70, 95% CI 0.67 to 4.32; 1 study, 99 participants; low-certainty evidence). There may be little or no difference in rates of noncompliance over 12 months between people using EU class 1 stockings and people using EU class 2 stockings (RR 1.22, 95% CI 0.40 to 3.75; 1 study, 99 participants; low-certainty evidence). UK class 2 hosiery compared with UK class 3 hosiery may be associated with a higher risk of reulceration over 18 months to 10 years (RR 1.55, 95% CI 1.26 to 1.91; 5 studies, 1314 participants; low-certainty evidence). People who use UK class 2 hosiery may be more compliant with compression treatment than people who use UK class 3 hosiery over 18 months to 10 years (RR for noncompliance 0.69, 95% CI 0.49 to 0.99; 5 studies, 1372 participants; low-certainty evidence). There may be little or no difference between Scholl UK class 2 compression stockings and Medi UK class 2 compression stockings in terms of reulceration (RR 0.77, 95% CI 0.47 to 1.28; 1 study, 166 participants; low-certainty evidence) and noncompliance (RR 0.97, 95% CI 0.84.1 to 12; 1 study, 166 participants; low-certainty evidence) over 18 months. No studies compared different lengths of compression (e.g. below-knee versus above-knee), and no studies measured duration of reulceration episodes, ulceration on the contralateral leg, proportion of follow-up without ulcers, comfort, or adverse effects. AUTHORS' CONCLUSIONS: Compression with EU class 3 compression stockings may reduce reulceration compared with no compression over six months. Use of EU class 1 compression stockings compared with EU class 2 compression stockings may result in little or no difference in reulceration and noncompliance over 12 months. UK class 3 compression hosiery may reduce reulceration compared with UK class 2 compression hosiery; however, higher compression may lead to lower compliance. There may be little to no difference between Scholl and Medi UK class 2 compression stockings in terms of reulceration and noncompliance. There was no information on duration of reulceration episodes, ulceration on the contralateral leg, proportion of follow-up without ulcers, comfort, or adverse effects. More research is needed to investigate acceptable modes of long-term compression therapy for people at risk of recurrent venous ulceration. Future trials should consider interventions to improve compliance with compression treatment, as higher compression may result in lower rates of reulceration.
Assuntos
Úlcera Varicosa , Humanos , Bandagens Compressivas , Meias de Compressão , Úlcera , Úlcera Varicosa/prevenção & controle , CicatrizaçãoRESUMO
OBJETIVO: Analisar a dosimetria do laser de baixa intensidade no processo de cicatrização de úlcera venosa. MÉTODO: Trata-se de um protocolo de revisão sistemática registrado no International Prospective Register of Systematic Reviews (PROSPERO) sob código de registro CRD420211256286. Serão realizadas buscas por evidências científicas em 11 bases de dados, utilizando os idiomas português, inglês e espanhol. A exportação das publicações seguirá as etapas de identificação e seleção dos estudos, e extração dos dados. As divergências serão resolvidas por consenso dos dois revisores, e caso persistam, um terceiro revisor será consultado para decidir sobre a inclusão do material. A ferramenta Risk of Bias 2 (RoB 2) será utilizada para avaliar o risco de viés dos estudos dos ensaios clínicos randomizados, ao passo que a ferramenta Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) será utilizada para avaliar o risco de viés dos ensaios clínicos não randomizados. A análise crítica dos materiais selecionados quanto à dosimetria do laser de baixa intensidade para cicatrização de úlcera venosa resultará em uma síntese narrativa, sem metanálise.
OBJECTIVE: To analyze the dosimetry of low-level laser therapy in the healing process of venous ulcers. METHOD: This is a protocol for systematic review registered in the International Prospective Register of Systematic Reviews under registry code CRD420211256286. Articles will be searched in 11 databases using Portuguese, English, and Spanish languages. The export of publications will follow the steps of study identification, selection, and data extraction. Disagreements will be resolved by consensus among reviewers; if they persist, a third reviewer will be consulted to decide whether to include the material. The Risk of Bias 2 (RoB 2) tool will be used to assess the validity of randomized clinical trials, while the Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) tool will be used to assess the risk of bias in non-randomized clinical trials. The critical analysis of selected materials on dosimetry of low-level laser therapy for venous ulcer healing will result in a narrative synthesis without meta-analysis.
Assuntos
Úlcera Varicosa/radioterapia , Cicatrização , Dosimetria , Terapia com Luz de Baixa Intensidade , Revisões Sistemáticas como AssuntoRESUMO
INTRODUCTION/OBJECTIVE: Venous Leg Ulcers (VLU) present a challenging healing process. Attaining healing is a primary treatment objective, commonly pursued in Primary Health Care (PHC) or Specialist Wound Management Clinics. Our objective was to examine the association and interplay between sociodemographic, health, clinical, and care factors with the outcomes of VLU treatment in patients undergoing care at a Specialist Wound Management Clinic. METHODS: Longitudinal, observational study took place in a center for the treatment of chronic injuries linked to PHC. The sociodemographic aspects, health status and habits, clinical and care aspects of patients with VLU were scrutinized over a 1-year period. RESULTS: The sample comprised 103 participants, with some still under treatment (Treatment Group-TG/ n = 60) and others having achieved VLU healing (Healing Group-HG/ n = 43). An association between sociodemographic, health, clinical, and care factors and the healing outcome (HG) was identified. A moderate correlation was observed between factors predisposing to healing in the sociodemographic group and health habits. Notably, among sociodemographic factors, the older age group and improvements in health, particularly the reduced use of alcohol/smoking, appeared to exert the most significant influence on healing. Additionally, specialized service monitoring and the application of compression therapy were contributory factors. CONCLUSIONS: These findings substantiate the hypothesis that sociodemographic, health, clinical, and care-related aspects are intertwined with VLU healing. Protective factors associated with healing interacted synergistically, fostering a positive outcome over one year of treatment.
Assuntos
Úlcera Varicosa , Humanos , Idoso , Úlcera Varicosa/tratamento farmacológico , Cicatrização , Fatores de Tempo , Nível de Saúde , Análise por ConglomeradosRESUMO
OBJECTIVE: To perform a comparative analysis of health care expenses and outcomes in response to the question: What is the cost-effectiveness of intralesional and perilesional recombinant human epidermal growth factor (rhEGF) compared with hydrocolloid therapy in patients diagnosed with chronic venous insufficiency without infection in Colombia? METHODS: A Markov model was used to determine cost effectiveness over a 5-year period, considering the perspective of the health system in Colombia. The study included patients aged >18 years diagnosed with chronic venous insufficiency and used clinical studies to calculate the probabilities of epithelialization, infection, recurrence, and mortality. RESULTS: RhEGF is more expensive per unit than hydrocolloids, but it is proven to be effective at healing ulcers in 8 to 12 weeks, even in complex cases. Hydrocolloids, in contrast, typically require 29.5 weeks on average, and ≤46 weeks for complex cases. Despite the cost, rhEGF is more cost effective because it achieves results comparable with hydrocolloid therapy at a lower cost per additional quality-adjusted life-year. CONCLUSIONS: Based on cost-effectiveness analysis, rhEGF is a superior alternative to hydrocolloids for treating venous ulcers in Colombia. Not only is it more affordable, but it also enhances patients' quality of life and streamlines the health care system's resource use.
Assuntos
Úlcera Varicosa , Insuficiência Venosa , Humanos , Úlcera Varicosa/diagnóstico , Úlcera Varicosa/tratamento farmacológico , Úlcera , Análise de Custo-Efetividade , Colômbia , Qualidade de Vida , Cicatrização , Coloides/uso terapêutico , Família de Proteínas EGF/uso terapêuticoRESUMO
Objetivo: Relatar a experiência da implantação de um protocolo assistencial voltado a pessoas com úlceras vasculares com foco nas úlceras venosas na atenção primária a saúde. Método:Trata-se de um estudo descritivo, realizado de março a julho de 2023, no Distrito Sanitário do Subúrbio Ferroviário, Salvador/BA. Resultados: A elaboração de um protocolo assistencial para pessoas com úlceras vasculares, com foco nas úlceras venosas, contou com apoio da enfermeira distrital, duas enfermeiras da assistência e um médico clínico e com a implementação dor referido protocolo por meio de reuniões online e presenciais para treinamento da verificação do índice tornozelo-braquial. Considerações finais:A elaboração do protocolo poderá favorecer a organização das unidades da atenção primária de modo que as pessoas portadoras de úlceras venosas possam receber um cuidado prestado de forma integral, holística e humanizada pelos profissionais que compõem a atenção primária a saúde.
Objective: To report the experience of implementing a care protocol aimed at people with vascular ulcers with a focus on venous ulcers in primary health care. Methodology: This is a descriptive study, carried out from March to July 2023, in the Health District of Subúrbio Ferroviário, Salvador/BA. Results: The development of a care protocol for people with vascular ulcers, focusing on venous ulcers, had the support of the district nurse, two care nurses and a clinical doctor and the implementation of this protocol through online and in-person meetings to training in checking the ankle-brachial index. Final considerations: The development of the protocol may favor the organization of primary care units so that people with venous ulcers can receive care provided in an integral, holistic and humanized manner by professionals who make up primary health care.
Objetivo: Reportar la experiencia de implementación de un protocolo de atención dirigido a personas con úlceras vasculares con enfoque en úlceras venosas en la atención primaria de salud. Metodología:Se trata de un estudio descriptivo, realizado de marzo a julio de2023, en el Distrito de Salud del Subúrbio Ferroviário, Salvador/BA. Resultados:El desarrollo de un protocolo de atención a personas con úlceras vasculares, con foco en las úlceras venosas, contó con el apoyo de la enfermera distrital, dos enfermeras asistenciales y un médico clínico y la implementación de este protocolo a través de reuniones online y presenciales para capacitaciones en comprobando el índice tobillo-brazo. Consideraciones finales: El desarrollo del protocolo puede favorecer la organización de las unidades de atención primaria para que las personas con úlceras venosas puedan recibir una atención brindada de manera integral, holística y humanizada por los profesionales que integran la atención primaria de salud.
Assuntos
Protocolos Clínicos , Atenção Primária à Saúde , Úlcera VaricosaRESUMO
ABSTRACT Objective: To analyze the effect of Unna's Boot on the healing of venous ulcers compared to other therapies. Methods: Systematic Review carried out in the databases Scopus, Embase, Cochrane Library, Web of Science, PubMed, Cumulative Index of Nursing and Allied Health Literature, Latin American and Caribbean Literature in Health Sciences, and grey literature. Population - adult patients with venous ulcers; Intervention- Unna's Boot (UB); Control - other compression therapies (CT); Outcome- healing; Designs- randomized clinical trial, cohort study, and case control, published from 2001 to 2024. The effect of the intervention, risk of bias, and quality of evidence were evaluated. Registered with PROSPERO (CRD42021290077). Results: A total of 39 studies were included, with 5.151 patients. The majority (71.8%) were randomized controlled trials (RCT). UB was used as intervention/control in eight studies. When comparing CTs, only 1 study with UB showed a superior effect (p < .001) in healing, compared with high compression elastic bandage. In the quality of evidence analysis, 27 studies were assessed as having a high risk of bias. Conclusion: No superiority of UB was found in the healing of venous ulcers when compared to other CTs.
RESUMEN Objetivo: Analizar el efecto de la Bota de Unna en la cicatrización de úlceras venosas en comparación con otras terapias. Métodos: Revisión sistemática realizada en las bases de datos Scopus, Embase, Biblioteca Cochrane, Web de la Ciencia, PubMed, Índice acumulativo de literatura de enfermería y salud afines, Literatura Latinoamericana y del Caribe en Ciencias de la Salud, y literatura gris. Población - pacientes adultos con úlceras venosas; Intervención- Bota de Unna (BU); Control: otras terapias de compresión (TC); Resultado- curación; Diseños: ensayo clínico aleatorizado, estudio de cohorte y casos y controles, publicado del 2002 al 2023. Se evaluaron el efecto de la intervención, el riesgo de sesgo y la calidad de la evidencia. Registrada en PRÓSPERO (CRD42021290077). Resultados: Se incluyeron 39 estudios, con 5.151 pacientes. La mayoría (71,8%) fueron ensayos controlados aleatorios (ECA). La BU se utilizó como intervención/control en ocho estudios. Al comparar TC, sólo 1 estudio con BU mostró un efecto superior (p < .001) en la curación, en comparación con el vendaje elástico de alta compresión. En el análisis de la calidad de la evidencia, se evaluó que 27 estudios tenían un alto riesgo de sesgo. Conclusión: No se encontró superioridad de la BU en la curación de úlceras venosas en comparación con otras TC.
RESUMO Objetivo: Analisar o efeito da Bota de Unna na cicatrização de úlceras venosas em comparação com outras terapias. Métodos: Revisão Sistemática realizada nas bases de dados Scopus, Embase, Cochrane Library, Web of Science, PubMed, Cumulative Index of Nursing and Allied Health Literature, Literatura Latino-Americana e do Caribe em Ciências da Saúde, e de literatura cinzenta. População- pacientes adultos com úlcera venosa; Intervenção- Bota de Unna (BU); Controle- outras terapias compressivas (TC); Desfecho- cicatrização; Delineamentos- ensaio clínico randomizado, estudo de coorte e caso controle, publicados de 2002 a 2023. Avaliaramu-se efeito da intervenção, risco de viés e qualidade da evidência. Registrada no PROSPERO (CRD42021290077). Resultados: Foram incluídos 39 estudos, com 5.151 pacientes. A maioria (71,8%) era ensaios clínicos randomizados (ECR). A BU foi utilizada como intervenção/controle em oito estudos. Na comparação entre TC, somente 1 estudo com BU apresentou efeito superior (p < .001) na cicatrização, comparado com atadura elástica de alta compressão. Na análise de qualidade da evidência, 27 estudos foram avaliados com alto risco de viés. Conclusão: Não foi encontrada superioridade da BU na cicatrização de úlceras venosas quando comparada com outras TC.
Assuntos
Humanos , Úlcera Varicosa , Metanálise , Revisão Sistemática , Meias de Compressão , Bandagens CompressivasRESUMO
BACKGROUND: Neuropathic and venous leg ulcers are chronic wounds associated with devitalized tissue and recurrent infection. Management should be guided by accurate tissue assessment, including the use of planimetry, which provides tissue types as a percentage of the total wound bed surface area. OBJECTIVE: This innovative study aimed to assess and identify the wound bed tissues, as a percentage, of neuropathic and venous ulcers using digital planimetry, providing support to nurses optimize the management of necrotic tissues and, consequently, to avoid wound infection. METHODS: This cross-sectional study enrolled 24 patients with chronic wounds who were assessed from January to March 2021 at the Wound Outpatients Clinic. The wound photographs were analyzed using Image J 1.53e and a smartphone with WoundDoc Plus® 2.8.2 via digital planimetry. Statistical analyses were performed using the binomial test, t-test, and Mann-Whitney. RESULTS: Median wound areas (p=0.3263) did not differ between the group with 2 or 3 risk factors for delayed healing (Md: 31.7) and the group with up to 1 risk factor (Md: 5.3). A low exudate level was associated with the up-to-1-risk-factor-for-delayed-healing group (p=0.0405), while a medium level was associated with the two-or-three-risk-factor group (p=0.0247). A heat map displayed the tissue percentages in the wound bed. In the group with 2 or 3 risk factors for delayed healing, 91.7% (11/12) had less than 70% granulation tissue, which was the primary factor for this group (p<0.0001). Additionally, 66.7% (8/12) of patients with 2 or 3 risk factors for delayed healing exhibited discolored and/or dark red granulation tissue as the primary factor (p=0.0130). CONCLUSION: This novel identification of wound area and tissue types as a percentage, using digital planimetry, can play a crucial role in assisting nurses in decision-making related to the appropriate management of devitalized tissues. Furthermore, this measurements may facilitate the conducting of virtual wound consultations and offer valuable support in the development of protocols aimed at preventing infection and biofilm formation in the wound bed.